Comprehensive analysis and identification of subtypes and hub genes of high immune response in lung adenocarcinoma
Abstract Background The advent of immunotherapy targeting immune checkpoints has conferred significant clinical advantages to patients with lung adenocarcinoma (LUAD); However, only a limited subset of patients exhibit responsiveness to this treatment. Consequently, there is an imperative need to st...
| 出版年: | BMC Pulmonary Medicine |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
BMC
2024-07-01
|
| 主題: | |
| オンライン・アクセス: | https://doi.org/10.1186/s12890-024-03130-6 |
